A Double-Blind Placebo-Controlled Study to Investigate the Action of Isoprinosine (Inosiplex) in Patients With Severe Acquired Immunodeficiency Syndrome
Patients with a history of gout, urolithiasis, nephrolithiasis, renal dysfunction, and
severe gastric ulcer are excluded.
- Cytotoxic immunosuppressive agents.
The following are excluded:
- Critically ill patients.
- Patients receiving steroids, cytotoxic immunosuppressive agents, radiotherapy.
- Patients who have received any other immunotherapy.
- Patients with a history of gout, urolithiasis, nephrolithiasis, renal dysfunction,
and severe gastric ulcer.
- Any other immunotherapy.
Patients with severe AIDS and specified laboratory immunologic defects.